Randall Stanicky analyst

Currently out of the existing stock ratings of Randall Stanicky, 87 are a HOLD (35.8%), 146 are a BUY (60.08%), 10 are a SELL (4.12%).

Randall Stanicky

Work Performance Price Targets & Ratings Chart

Analyst Randall Stanicky works with a stock forecast success ratio of 38.17% fulfilled within 152.46 days on average. Previously, Randall Stanicky worked at RBC.

Randall Stanicky’s has documented 435 price targets and ratings displayed on 27 stocks. The coverage was on the Healthcare sector.

Most recent stock forecast was given on AQST, Aquestive Therapeutics at 07-Apr-2021.

Wall Street Analyst Randall Stanicky

Analyst best performing recommendations are on NEOS (NEOS THERAPEUTICS).
The best stock recommendation documented was for PCRX (PACIRA PHARMACEUTICALS) at 1/6/2021. The price target of $70 was fulfilled within 2 days with a profit of $7.05 (11.2%) receiving and performance score of 56.

Average potential price target upside

ABBV AbbVie ACRX AcelRx Pharmaceuticals AGN Allergan plc AGRX Agile Thrpe AKRX Akorn AMRX Amneal Pharmaceuticals, . Common Stock EGRX Eagle Pharmaceuticals ENDP Endo International PLC FLXN Flexion Therapeutics INSY INSYS Therapeutics JAZZ Jazz Pharmaceuticals PLC KMPH KemPharm MRK Merck mpany MYL Viatris OSMT Osmotica Pharmaceuticals plc PCRX Pacira Pharmaceuticals PFE Pfizer PRGO Perrigo Company PLC SGNT Sagent Pharmaceuticals TEVA Teva Pharma Industries Ltd ADR VTRS Viatris XERS Xeris Pharmaceuticals AQST Aquestive Therapeutics ASRT Assertio Therapeutics NEOS Neos Therapeutics OPTN OptiNose RVLP RVL Pharmaceuticals PLC

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

189

$12.25 (6.93%)

181

20 days ago

9/13 (69.23%)

$20.33 (12.05%)

256

Buy

185

$8.25 (4.67%)

175

20 days ago

11/12 (91.67%)

$16.33 (9.68%)

140

Buy

195

$18.25 (10.33%)

180

20 days ago

7/10 (70%)

$26.33 (15.61%)

402

Hold

156

$-20.75 (-11.74%)

167

2 months 8 days ago

2/2 (100%)

$2.58 (1.68%)

109

Buy

173

$-3.75 (-2.12%)

122

2 months 15 days ago

1/3 (33.33%)

$21.76 (14.39%)

58

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What Year was the first public recommendation made by Randall Stanicky?

On 2012

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?